AUTLVSBIAF• 3 Months (Normalized)
AUTL vs BIAF (Autolus Therapeutics plc vs bioAffinity Technologies Inc.)
Showing Closing Date Range from Jun, 19 to Sep, 17, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
AUTL Performance $1.92
+28.86%
Autolus Therapeutics plc
Normalized Baseline0.00%
BIAF Performance $9.07
-25.35%
bioAffinity Technologies Inc.
Normalized Baseline0.00%
Alpha Spread Margin AUTL LEADS
+54.21%
AUTL outperforming by 54.21%
AUTLBIAF
Spread Trajectory3 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
AUTL BIAF
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(62 dates)
| Date | AUTL Price | AUTL Gain (%) | BIAF Price | BIAF Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 17, 2026 | $1.92 | +28.86% | $9.07 | -25.35% | +54.21% |
| Sep 16, 2026 | $1.87 | +25.50% | $5.35 | -55.97% | +81.47% |
| Sep 15, 2026 | $1.89 | +26.85% | $6.36 | -47.65% | +74.50% |
| Sep 14, 2026 | $1.94 | +30.20% | $7.93 | -34.73% | +64.93% |
| Sep 11, 2026 | $1.88 | +26.17% | $7.95 | -34.57% | +60.74% |
| Sep 10, 2026 | $1.96 | +31.54% | $9.39 | -22.72% | +54.26% |
| Sep 09, 2026 | $2.03 | +36.24% | $10.50 | -13.58% | +49.82% |
| Sep 08, 2026 | $2.11 | +41.61% | $8.93 | -26.50% | +68.11% |
| Sep 04, 2026 | $2.24 | +50.34% | $15.27 | +25.68% | +24.66% |
| Sep 03, 2026 | $2.29 | +53.69% | $12.78 | +5.19% | +48.50% |
| Sep 02, 2026 | $2.24 | +50.34% | $9.75 | -19.75% | +70.09% |
| Sep 01, 2026 | $2.31 | +55.03% | $6.59 | -45.76% | +100.79% |
| Aug 31, 2026 | $2.35 | +57.72% | $4.56 | -62.47% | +120.19% |
| Aug 28, 2026 | $2.34 | +57.05% | $4.87 | -59.92% | +116.97% |
| Aug 27, 2026 | $2.36 | +58.39% | $5.06 | -58.35% | +116.74% |
Page 1 of 5